[Cardiotoxicity of drugs used in the treatment of malignant neoplasms].
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced*; D003520:Cyclophosphamide / Q000009:adverse effects; D004317:Doxorubicin / Q000009:adverse effects; D004359:Drug Therapy, Combination / Q000009:adverse effects; D005472:Fluorouracil / Q000009:adverse effects; D006333:Heart Failure / Q000139:chemically induced*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D004317:Doxorubicin; D003520:Cyclophosphamide; D005472:Fluorouracil
Kardiotoksyczność leków stosowanych w leczeniu nowotworów złośliwych.